Chelation Therapy In Switzerland -- Prevents Cancer
Write To Karl Loren About This Page
Source (This original source is now missing!)
|
Chelation |
Chelation Therapy
(key-LAY-shun)
Cardiovascular Diseases
New Help For:
- heart disease
- high blood pressure
- failing memory or sight
A little-known therapy just a few years ago, chelation (key-LAY-shun) is now gaining attention as a viable alternative to coronary bypass surgery, angioplasty and circulation problems.
Chelation therapy is the intravenous administration of an artificial amino acid (EDTA) combined with other nutrients to remove toxic metals. These toxic metals increase the amount of destructive chemical substances which cause cellular breakdown and contribute to hardening of the arteries.
[Karl Note: Why can't they tell the truth here? The toxic metals cause an increase of free radicals, and when someone claims that the problem is with "destructive chemical substances" it sounds like there could be a "chemical solution" to the problem. There is no chemical, no drug, which can reverse the destruction done by free radicals. The remedy lies in removing the SOURCE of the creation of the free radicals -- the toxic metals.
It is common for many authors, even in the field of "alternative health" to miss the main importance of the role of free radicals. Antioxidants can and do neutralize free radicals, but antioxidants do NOT remove the source of multiplication. My oral chelation DOES remove the source, thus greatly reduces free radical formation in the body -- leading to better blood circulation and thus, fewer problems with heart disease or cancer.
Why isn't this big news!]
According to the book Forty Something Forever, written by Harold and Arline Brecher,the procedure helps your body decrease plaque in the arteries and increase blood flow to organs and extremities. The scientific research they reviewed shows:
-
"Inhibition of platelet aggregation (blood stickiness) in humans within three minutes of EDTA infusion;
12 to 20% improved pulmonary [lung] function ... following 30 chelation treatments in 90.5% of 38 patients with independently diagnosed chronic lung disorders;
Marked improvement in 91% (and good improvement in 8%) in 1,130 patients with peripheral vascular disease [hardening of the arteries] and intermittent claudication [pain in legs upon walking] over a 28-month treatment period;
Marked improvement in 76.9% (and good improvement in 17%) of 844 patients with ischemic heart disease over a 28-month treatment period;
Marked or good improvement in 89% of all 2,870 patients treated over a 28-month period, no matter what their presenting health problems; ...
35% reduction in serious (76.63%) carotid artery blockage and 620% increase in blood flow in 16 men and women after ten months of EDTA infusions; ...
Documented evidence of the long-term success of EDTA chelation as an alternative to amputation in four patients originally scheduled for surgery."
After providing Chelation Therapy for a number of years, we have come across outstanding stories and statistics regarding this marvelous treatment. For example we would like to share some findings dealing with EDTA Chelation from a recent article: According to Alternative Medicine Review, Volume 3, 1 , 1998,"...although it has not been subjected to vast numbers of clinical trials, two meta-analysises suggest EDTA chelation therapy benefits cardiovascular symptoms in more than four out of five patients. In 1993, Chappell and Stahl published an analysis of data on 22,765 patients, compiled from 19 published clinical studies. They found a correlation coefficient of 87 percent between EDTA therapy and improved cardiovascular symptomatology based on objective testing. Subsequently, they obtained unpublished file drawer data on 1,241 objectively-sorted patients from 32 clinicians. From this approach they obtained a correlation co-efficient of 88 percent, further building the case for cardiovascular benefit from EDTA.
Danish physicians Hancke and Flytlie reported retrospectively on 470 patients with atherosclerosis. Of 65 patients awaiting bypass surgery and subjected to chelation, the vast majority showed clinical improvement; when chelation was completed only seven still required bypass. Of 27 patients previously scheduled for leg amputation, only three required surgery following courses of chelation therapy. These enticing results from EDTA chelation invite a well controlled comparison of chelation and revascularization, with the hope of being able to replace surgical revascularization techniques or to use chelation as an adjunct to these interventions.
We'd
like to give you some interesting history about
Chelation Therapy and cancer.
Beginning in 1958, a lengthy study was conducted in
Switzerland on 231 adults who lived near a
well-traveled highway and had a higher rate of cancer
mortality than other people in the same city that
lived in traffic-free areas. The study group also
suffered from a higher incidence of nervous
disorders, headaches, fatigue, gastrointestinal
disorders, depression and substance abuse. The
researchers suggested that their symptoms might be
due to a higher level of exposure to lead from
automobile exhausts. Then, in 1961, 59 patients from
this group received ten or more EDTA chelation
treatments served as control subjects. An
eighteen-year follow-up study of the group conducted
by Walter Blumer, M.D. of Nestal, Switzerland
revealed that only one of the 59 treated patients
died of cancer (1.7 percent) as compared to thirty
deaths (17.6 percent) from cancer among the
non-treated subjects. This is a 90 percent reduction
of mortality from cancer. Dr. Blumer found that death
from atherosclerosis was also reduced among the
treated patients. His findings were based upon Swiss
death certificates and statistical evidence showing
that EDTA chelation therapy was the only significant
difference between the control group and the treated
patients. This information was resourced from
Burton Goldberg's book, Alternative Therapies.
[Karl Note: The more accurate reference for the source is HERE.]
|
I promise to answer your message -- click here to send me a personal message
|
SUBSCRIBE: The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren. You can view more than 50 back issues of this publication by clicking here. The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter. It is automatically published on the Tuesday night just before the first Wednesday of every month. You can subscribe to this free monthly electronic letter by entering your eMail address and name below. You will then automatically receive a request for confirmation, sent to whatever address you have entered. If you do NOT receive this confirmation request, then you will not be subscribed. There may have been an error with your address and you should resubmit. The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription. When you receive this confirmation request you must reply to it, or your subscription will not become active. No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.
REMOVAL: You can remove yourself from the subscription list in several different ways. Click here to read about this entire newsletter system. Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list. If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed. Thus, no one else can unsubscribe you, from some other computer, without your knowledge. But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.
Personal Message: When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions. Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US. You can select particular information you would like to receive, along with the free cassette tape and catalog.
You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504. Within the US and Canada, use the toll free number: (800) 523-4521, the local number: (818) 558-1799, the FAX: (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites. Vibrant Life normally ships the same day we get an order. There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life. Check out our companion site, at: http://www.oralchelation.net where Karl's 2000 page book is published. Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION. His personal philosophical articles are at PHILOSOPHY.
Copyright © May 20, 2008 6:24 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED. Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions: One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site. This permission does not extend to materials on this site which are copyrighted by others.